Our Mission

Our mission is to remove barriers in preclinical development by applying our knowledge, infrastructure, and partnerships to transform promising drug therapy concepts into IND-enabling product opportunities.

 

Our Vision

We are focused on building, innovating, collaborating, and committing:

  • To Build. We build on a strong foundation in early-stage drug discovery, expanding our role as a partner that helps promising compounds reach clinical development.

  • To Innovate. We work with industry and academia in scientific and business disciplines to advance preclinical drug assets to IND.

  • To Collaborate. We integrate people, process, and partnerships to move ideas forward.

  • To Commit. We take an active stake in success through collaborative investment and meaningful engagement.

 

Our Facility

TSRL’s headquarters includes 7,200 sq. ft. of highly specialized lab and operational space:

  • AAALAC-accredited vivarium supporting in vivo studies in rodents

  • Formulation lab equipped for solubility screening, prototype formulation development, and stability testing

  • Analytical and bioanalytical lab with HPLC, LC-MS/MS, spectrophotometry, and more

  • Climate-controlled storage

  • Office and collaboration space for client teams and resident projects

Request an on-site tour of our facility here.

 

Our Leadership

TSRL is powered by leaders who have spent decades bringing therapies to market. Each senior team member brings more than 35 years of experience in pharmaceutical R&D, including roles across clinical development, regulatory strategy, product commercialization, and licensing from large pharma.

 
 

TSRL in the News

 

Ready to Discuss Your Program?

Connect with a TSRL scientist to understand how our preclinical CRO services can support your team and your next milestone.